RxDoctor Payments Data

Scott Hahn, DO

Family Medicine · Lancaster, OHNPI 1003171695

Payments from drug & device makers

$4,802in general payments, 2019–2025

Across 280 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$704
  • Novo Nordisk$557
  • Pfizer$484
  • AstraZeneca$264
  • Exact Sciences$263
  • Lilly USA, LLC$230
  • plus $2K from 36 others

What the payments were for

  • Speaking & faculty fees$130%
  • Food & beverage$4,789100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,802 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$103,998
Medicare patients
179
Services billed
2,983

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban100$87,097
EliquisApixaban72$60,842
JanuviaSitagliptin Phosphate75$55,934
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$30,804
JardianceEmpagliflozin28$28,310
OzempicSemaglutide21$22,772
Tresiba Flextouch U-100Insulin Degludec13$14,106
Tresiba Flextouch U-200Insulin Degludec13$9,275
Arnuity ElliptaFluticasone Furoate20$7,491
Advair HfaFluticasone Propion/Salmeterol13$5,243
Rosuvastatin Calcium359$5,217
Fluticasone-SalmeterolFluticasone Propion/Salmeterol28$4,843
Breo ElliptaFluticasone/Vilanterol12$4,654
Atorvastatin Calcium415$4,532
Memantine Hcl64$4,200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$74$87,097100 claims
PfizerEliquis, Paxlovid$484$63,70090 claims
MerckJanuvia$142$55,93475 claims
GSKTrelegy Ellipta, Arnuity Ellipta, Breo Ellipta, Shingrix$121$47,10996 claims
Boehringer IngelheimJardiance$212$28,31028 claims
Novo NordiskOzempic$557$22,77221 claims
AbbVieSynthroid$704$1,28237 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Lancaster

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →